Goldenrod Therapeutics

Seed
goldenrodtx.com Biotech & Healthcare Houston, United States
Total Funding $6.5M
Latest Round $6.5M Seed
Last Announced Jun 4, 2026
Investors Undisclosed
Decision Makers Profile Active

About Goldenrod Therapeutics

Goldenrod Therapeutics develops a small molecule to prevent pathogenic activity in immune cells.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Houston, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website goldenrodtx.com
Domain Registered Date Nov 5, 2020

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $6,500,000 · Seed

    Silicon Prairie News

  2. Milestone

    Website domain registered

    goldenrodtx.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Goldenrod Therapeutics.

Funding History

1 Round
Seed · Jun 4, 2026

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts